These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17593366)

  • 1. Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid.
    Tong A; Zhang H; Li Z; Gou L; Wang Z; Wei H; Tang M; Liang S; Chen L; Huang C; Wei Y
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):791-802. PubMed ID: 17593366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
    Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of suberoylanilide hydroxamic acid against thyroid cancer cell lines in vitro and in vivo.
    Luong QT; O'Kelly J; Braunstein GD; Hershman JM; Koeffler HP
    Clin Cancer Res; 2006 Sep; 12(18):5570-7. PubMed ID: 17000694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of cisplatin cytotoxicity by SAHA involves endoplasmic reticulum stress-mediated apoptosis in oral squamous cell carcinoma cells.
    Suzuki M; Endo M; Shinohara F; Echigo S; Rikiishi H
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1115-22. PubMed ID: 19280190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma.
    Dalgard CL; Van Quill KR; O'Brien JM
    Clin Cancer Res; 2008 May; 14(10):3113-23. PubMed ID: 18483379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
    Yan XD; Pan LY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].
    Zhang XP; Xiao ZQ; Chen ZC; Li C; Li JL; Yu YH; Ouyang YM; Feng XP; Zhang PF
    Ai Zheng; 2006 Jan; 25(1):22-8. PubMed ID: 16405744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
    Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
    Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages.
    Wang WJ; Tang W; Qiu ZY
    Ai Zheng; 2009 Feb; 28(2):117-21. PubMed ID: 19550115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of apoptosis induced by trichostatin A in leukemia Molt-4 cells analyzed by microarray].
    Hong ZY; Yi LS; Miao XY; Lu YP; Zhou JF; Liu WL
    Ai Zheng; 2006 Aug; 25(8):946-53. PubMed ID: 16965673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
    Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
    Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteomic analysis of rat astrocytes and C6 glioma cells].
    Gao YL; Liu P; Sun HL; Liu M
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3421-4. PubMed ID: 18476543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells.
    Chen G; Li A; Zhao M; Gao Y; Zhou T; Xu Y; Du Z; Zhang X; Yu X
    J Proteome Res; 2008 Jul; 7(7):2733-42. PubMed ID: 18549279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative proteomics analysis of the proteins associated with laryngeal carcinoma-related gene 1.
    Zhang X; Xiao Z; Chen Z; Li C; Li J; Yanhui Y; Yang F; Yang Y; Oyang Y
    Laryngoscope; 2006 Feb; 116(2):224-30. PubMed ID: 16467709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening proteins related to retinoic acid resistance by proteomic analysis].
    Qin H; Liu T; Yang JL; Huang X; Liu B; Song X; Zhao X; Wei YQ
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):520-5. PubMed ID: 17459200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orlistat, a novel potent antitumor agent for ovarian cancer: proteomic analysis of ovarian cancer cells treated with Orlistat.
    Huang HQ; Tang J; Zhou ST; Yi T; Peng HL; Shen GB; Xie N; Huang K; Yang T; Wu JH; Huang CH; Wei YQ; Zhao X
    Int J Oncol; 2012 Aug; 41(2):523-32. PubMed ID: 22581080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
    Suzuki T; Nagano Y; Kouketsu A; Matsuura A; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
    J Med Chem; 2005 Feb; 48(4):1019-32. PubMed ID: 15715470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells.
    Komatsu N; Kawamata N; Takeuchi S; Yin D; Chien W; Miller CW; Koeffler HP
    Oncol Rep; 2006 Jan; 15(1):187-91. PubMed ID: 16328054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.